Immunoadsorption for Treatment of Alzheimer's Disease

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

NCT00657813 ·Status: TERMINATED ·Phase: PHASE1

Longitudinal Monitoring of Cerebral Connectivity 3T MRI in Patients With a Transcient Global Amnesia

NCT02796287 ·Status: TERMINATED ·Phase: NA

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3

Continuous Arterial Spin Labeling (CASL) MRI for Monitoring and Prediction of Drug Therapy in Alzheimers Disease (AD)

NCT00637442 ·Status: UNKNOWN ·Phase: NA

Implications for Management of PET Amyloid Classification Technology in the Imaging Dementia(IDEAS) Trial

NCT02781220 ·Status: TERMINATED

PET Imaging of Brain Amyloid Using [11C]MeS-IMPY

NCT00407576 ·Status: COMPLETED ·Phase: PHASE1

Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease

NCT01095744 ·Status: COMPLETED

HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease

NCT02638519 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Imaging Inflammation in Alzheimer's Disease

NCT02831283 ·Status: COMPLETED ·Phase: PHASE2

ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease

NCT03739905 ·Status: COMPLETED ·Phase: NA

Amyloid Beta-peptide 1-40 and Alzheimer's Disease

NCT02770482 ·Status: COMPLETED ·Phase: NA

An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease

NCT01325402 ·Status: COMPLETED ·Phase: PHASE1

Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for β Amyloid

NCT00692705 ·Status: COMPLETED ·Phase: PHASE1

Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants

NCT02685969 ·Status: RECRUITING

FluoroAv45 Imaging Research-in Alzheimer's Disease

NCT01325259 ·Status: COMPLETED ·Phase: PHASE2

PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) Radioligand

NCT03958630 ·Status: TERMINATED ·Phase: PHASE1

Alzheimer's Disease Neuroimaging Initiative 2

NCT01231971 ·Status: COMPLETED

To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI

NCT03530462 ·Status: COMPLETED

Imaging Tau Deposition in the Brain of Elderly Subjects

NCT02958670 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

New Biomarker for Alzheimer's Disease Diagnostic

NCT01315639 ·Status: COMPLETED ·Phase: NA

the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous Nephropathy

NCT06245707 ·Status: UNKNOWN ·Phase: NA

Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders

NCT00001362 ·Status: COMPLETED

Multi-modal Neuroimaging in Alzheimer's Disease

NCT01554202 ·Status: UNKNOWN ·Phase: NA

The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180)

NCT03702816 ·Status: TERMINATED ·Phase: PHASE2

Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.

NCT07105956 ·Status: NOT_YET_RECRUITING